GILEAD SCIENCES INC (GILD) Stock Fundamental Analysis

NASDAQ:GILD • US3755581036

154.98 USD
+3.17 (+2.09%)
At close: Feb 13, 2026
154.98 USD
0 (0%)
After Hours: 2/13/2026, 8:13:27 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Overall GILD gets a fundamental rating of 6 out of 10. We evaluated GILD against 522 industry peers in the Biotechnology industry. GILD scores excellent on profitability, but there are some minor concerns on its financial health. GILD has a decent growth rate and is not valued too expensively. GILD also has an excellent dividend rating. With these ratings, GILD could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • GILD had positive earnings in the past year.
  • GILD had a positive operating cash flow in the past year.
  • Of the past 5 years GILD 4 years were profitable.
  • GILD had a positive operating cash flow in 4 of the past 5 years.
GILD Yearly Net Income VS EBIT VS OCF VS FCFGILD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • The Return On Assets of GILD (13.86%) is better than 94.84% of its industry peers.
  • GILD has a Return On Equity of 37.80%. This is amongst the best in the industry. GILD outperforms 98.28% of its industry peers.
  • With an excellent Return On Invested Capital value of 18.54%, GILD belongs to the best of the industry, outperforming 97.51% of the companies in the same industry.
  • GILD had an Average Return On Invested Capital over the past 3 years of 16.22%. This is below the industry average of 18.26%.
  • The last Return On Invested Capital (18.54%) for GILD is above the 3 year average (16.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
GILD Yearly ROA, ROE, ROICGILD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 27.88%, GILD belongs to the top of the industry, outperforming 95.41% of the companies in the same industry.
  • GILD's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 38.96%, GILD belongs to the best of the industry, outperforming 98.28% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GILD has grown nicely.
  • GILD's Gross Margin of 78.72% is amongst the best of the industry. GILD outperforms 84.89% of its industry peers.
  • In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
GILD Yearly Profit, Operating, Gross MarginsGILD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • GILD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GILD Yearly Shares OutstandingGILD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GILD Yearly Total Debt VS Total AssetsGILD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • There is no outstanding debt for GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.56
WACC11.86%
GILD Yearly LT Debt VS Equity VS FCFGILD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • GILD has a Current Ratio of 1.53. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.53, GILD is not doing good in the industry: 80.50% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.17 indicates that GILD should not have too much problems paying its short term obligations.
  • The Quick ratio of GILD (1.17) is worse than 83.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
GILD Yearly Current Assets VS Current LiabilitesGILD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • Measured over the past 5 years, GILD shows a small growth in Earnings Per Share. The EPS has been growing by 2.83% on average per year.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%

3.2 Future

  • Based on estimates for the next years, GILD will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.47% on average per year.
  • Based on estimates for the next years, GILD will show a small growth in Revenue. The Revenue will grow by 4.32% on average per year.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
GILD Yearly Revenue VS EstimatesGILD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GILD Yearly EPS VS EstimatesGILD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 19.02, GILD is valued on the expensive side.
  • Based on the Price/Earnings ratio, GILD is valued cheaply inside the industry as 94.84% of the companies are valued more expensively.
  • GILD is valuated rather cheaply when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
  • GILD is valuated rather expensively with a Price/Forward Earnings ratio of 17.38.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GILD indicates a rather cheap valuation: GILD is cheaper than 94.26% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, GILD is valued a bit cheaper.
Industry RankSector Rank
PE 19.02
Fwd PE 17.38
GILD Price Earnings VS Forward Price EarningsGILD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GILD is valued cheaper than 95.79% of the companies in the same industry.
  • GILD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GILD is cheaper than 95.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.2
EV/EBITDA 12.97
GILD Per share dataGILD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GILD does not grow enough to justify the current Price/Earnings ratio.
  • GILD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.01
PEG (5Y)6.73
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • GILD has a Yearly Dividend Yield of 2.16%.
  • Compared to an average industry Dividend Yield of 1.17, GILD pays a better dividend. On top of this GILD pays more dividend than 98.47% of the companies listed in the same industry.
  • GILD's Dividend Yield is comparable with the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 4.45%.
  • GILD has paid a dividend for at least 10 years, which is a reliable track record.
  • As GILD did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.45%
Div Incr Years9
Div Non Decr Years9
GILD Yearly Dividends per shareGILD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 12.00% of the earnings are spent on dividend by GILD. This is a low number and sustainable payout ratio.
  • GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
GILD Yearly Income VS Free CF VS DividendGILD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
GILD Dividend Payout.GILD Dividend Payout, showing the Payout Ratio.GILD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILEAD SCIENCES INC

NASDAQ:GILD (2/13/2026, 8:13:27 PM)

After market: 154.98 0 (0%)

154.98

+3.17 (+2.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner Change-90.42%
Ins Owners0.07%
Ins Owner Change0.67%
Market Cap192.28B
Revenue(TTM)N/A
Net Income(TTM)8.11B
Analysts81.62
Price Target142.32 (-8.17%)
Short Float %1.85%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend3.14
Dividend Growth(5Y)4.45%
DP12%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)5.14%
PT rev (3m)9.72%
EPS NQ rev (1m)-2.64%
EPS NQ rev (3m)-3.29%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)0.64%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 19.02
Fwd PE 17.38
P/S 6.61
P/FCF 20.2
P/OCF 19.89
P/B 8.96
P/tB N/A
EV/EBITDA 12.97
EPS(TTM)8.15
EY5.26%
EPS(NY)8.92
Fwd EY5.76%
FCF(TTM)7.67
FCFY4.95%
OCF(TTM)7.79
OCFY5.03%
SpS23.44
BVpS17.29
TBVpS-3.89
PEG (NY)2.01
PEG (5Y)6.73
Graham Number56.31
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC11.86%
ROIC/WACC1.56
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.26%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / GILD FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?

ChartMill assigns a fundamental rating of 6 / 10 to GILD.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.


How profitable is GILEAD SCIENCES INC (GILD) stock?

GILEAD SCIENCES INC (GILD) has a profitability rating of 8 / 10.


What is the valuation of GILEAD SCIENCES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (GILD) is 19.02 and the Price/Book (PB) ratio is 8.96.


How sustainable is the dividend of GILEAD SCIENCES INC (GILD) stock?

The dividend rating of GILEAD SCIENCES INC (GILD) is 7 / 10 and the dividend payout ratio is 12%.